Vernalis Research Limited
Records under this name other than patents Vernalis Research Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Vernalis Research Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,141,575 | Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists Formerly held Term ended Term ended May 15, 2022 · USPTO record | Term ended | Term ended May 15, 2022 | USPTO record |
| US 7,405,219 | Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists Formerly held Term ended Term ended Jan 10, 2022 · USPTO record | Term ended | Term ended Jan 10, 2022 | USPTO record |
| US 7,589,097 | Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists Formerly held Term ended Ended no later than Jan 10, 2022 · USPTO record | Term ended | Ended no later than Jan 10, 2022 | USPTO record |
| US 6,403,574 | Azetidinecarboxamide derivatives for treating CNS disorders Formerly held Term ended Term ended Sep 17, 2021 · USPTO record | Term ended | Term ended Sep 17, 2021 | USPTO record |
| US 6,831,078 | Azetidinecarboxamide derivatives for treating CNS disorders Formerly held Term ended Term ended Feb 12, 2021 · USPTO record | Term ended | Term ended Feb 12, 2021 | USPTO record |
| US 7,098,333 | Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists Lapsed on the fee record Ended Aug 29, 2014 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2014 | USPTO record |
| US 7,098,337 | 1,2,3,4,9,9a-Hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives Formerly held Lapsed on the fee record Ended Aug 29, 2014 · High confidence | Lapsed on the fee record | Ended Aug 29, 2014 | High confidence |
| US 7,087,754 | Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists Lapsed on the fee record Ended Aug 8, 2014 · USPTO record | Lapsed on the fee record | Ended Aug 8, 2014 | USPTO record |
| US 6,372,102 | Method for reducing charge in gas diffusing electrode and its charge reducing structure Formerly held Lapsed on the fee record Ended Apr 16, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 16, 2014 | USPTO record |
| US 7,022,707 | Piperazine derivatives Lapsed on the fee record Ended Apr 4, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2014 | USPTO record |